Allergy/Imm Medical News

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Novel therapies for children with severe asthma

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Evaluation of desloratadine on conjunctival allergen challenge-induced ocular symptoms
Clinical and Experimental Allergy, 06/15/09

Torkildsen GL et al. - Desloratadine was significantly more effective than placebo in preventing post-challenge ocular pruritus. Significant improvements post-challenge were also seen in ciliary and episcleral redness, chemosis, eyelid swelling, and tearing. Desloratadine was well tolerated. Treatment with desloratadine 5 mg daily for 7 days reduced allergic ocular symptoms following allergen challenge.

<< Previous
AMA: Better care guidelines would slow health spending

Next >>
The bronchial response to mannitol is attenuated by a previous...